Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
11/2010
11/23/2010US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
11/23/2010US7837981 Methods for imaging soluble A-beta
11/23/2010US7836898 Reduced tendency of cigarretes to ignite fire-prone substrates by using a permeability reducing substance, a burn rate retardant and a burn rate accelerant that also act as an organoleptic enhancers
11/23/2010CA2487489C Mitotic kinesin inhibitors
11/23/2010CA2459380C Reverse hydroxamic acid derivatives
11/18/2010WO2010132601A1 Antiviral compounds
11/18/2010WO2010132524A1 2-azatriphenylene materials for organic light emitting diodes
11/18/2010WO2010132247A1 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010WO2010131764A1 Organic semiconductor material, organic semiconductor thin film, and organic thin-film transistor
11/18/2010WO2010131738A1 Azetidine compound and medicinal use thereof
11/18/2010WO2010131669A1 3-(4-aminophenyl)-2-furancarboxylic acid derivative and pharmaceutically acceptable salt thereof
11/18/2010WO2010130794A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010WO2010033543A3 Substituted benzamides as cannabinoid receptor ligands
11/18/2010US20100292293 Therapeutic substituted lactams
11/18/2010US20100292276 Benzimidazole derivatives useful as trp m8 receptor modulators
11/18/2010US20100292273 Cannabinoid Receptor Modulators
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292190 Novel tubulin polymerisation inhibitors
11/18/2010US20100291222 Antioxidant nanosphere comprising [1,2]-dithiolane moieties
11/18/2010US20100289406 2-azatriphenylene materials for organic light emitting diodes
11/18/2010CA2761858A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
11/18/2010CA2761258A1 Antiviral compounds
11/17/2010EP2251335A1 Branched compounds, organic thin films made by using the same, and organic thin film devices
11/17/2010EP2250160A1 Thiophenes and their use as phosphatidylinositol 3-kinase (pi3k) inhibitors
11/17/2010EP2250158A2 Angiotensin ii receptor antagonists
11/17/2010EP2250155A1 5h-cyclopenta[d]pyrimidines as akt protein kinase inhibitors
11/17/2010EP2250152A1 Quinolines as inhibitors of farnesyl pyrophosphate synthase
11/17/2010EP2250151A1 Compounds having electroluminescent or electron transport properties
11/17/2010EP2249828A1 Preparation of sulfamide derivatives
11/17/2010EP1899296B1 Histamine-3 receptor antagonists
11/17/2010EP1778671B1 Piperazine derivatives with ccr3 inhibiting activity
11/17/2010CN101889009A Inhibitors of c-fms kinase
11/17/2010CN101889007A Method for amplifying hematopoietic stem cells using heterocyclic compound
11/17/2010CN101889004A Inhibitors of protein kinases
11/17/2010CN101888997A Synthesis of quaternary salt compounds
11/17/2010CN101885699A Method for synthesizing chiral polycyclic compounds having butyrolactam skeletons
11/16/2010US7834199 Small molecular thiophene compound having divalent linkage
11/16/2010US7834188 Insecticidal N-substituted sulfoximines
11/16/2010US7834186 Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates
11/16/2010US7834054 Hydroxamates as therapeutic agents
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834046 Thiophene compounds
11/16/2010US7834034 Benzothiophene derivatives
11/16/2010US7834021 3-aminopyrrolidine derivatives as modulators of chemokine receptors
11/16/2010US7834002 4-amino-5-cyanopyrimidine derivatives
11/16/2010US7833999 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide
11/16/2010CA2427548C Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them
11/16/2010CA2396824C Heteroaromatic carboxamide derivatives and their use as inhibitors of the enzyme ikk-2
11/11/2010WO2010129467A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010WO2010129451A1 Process for preparing bromo-substituted quinolines
11/11/2010WO2010128659A1 Diamino heterocyclic carboxamide compound
11/11/2010WO2010128058A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010WO2007143597A9 Organic compounds
11/11/2010US20100286212 Treating and Preventing Viral Infections
11/11/2010US20100286207 Novel 2-Oxo-Heterocyclic Compounds And The Pharmaceutical Compositions Comprising The Same
11/11/2010US20100286158 Dihydropyrimidinones
11/11/2010US20100286152 N-phenyl hydrazides as modulators of the ghrelin receptor
11/11/2010US20100286135 Heterocyclic amide compounds as protein kinase inhibitors
11/11/2010US20100286118 Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750
11/11/2010US20100286103 Heterocycle-aryl compounds for inflammation and immune-related uses
11/11/2010CA2764232A1 Novel heterocyclic compounds
11/11/2010CA2761009A1 Compounds and methods for inhibition of renin, and indications therefor
11/11/2010CA2760343A1 Dihydropyrimidinones for use as bace2 inhibitors
11/11/2010CA2760061A1 Diamino heterocyclic carboxamide compound
11/10/2010EP2248812A2 Fused cyclic compounds as GPR40 receptor modulators
11/10/2010EP2248811A1 2-oxochromene derivative
11/10/2010EP2248809A1 Alkyl-3-[2-(benzo[b]thiophen-5-yl)-ethoxy]-propanoates as intermediates in the production of Azetidin-3-ol derivatives
11/10/2010EP2248423A1 Composition for agricultural use for controlling or preventing plant diseases caused by plant pathogens
11/10/2010EP2247575A2 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
11/10/2010EP1940407B1 N-(4-oxo-3,4-dihydroquinazolin-2-yl)butanamides as androgen receptor modulators
11/10/2010EP1869024B1 New tricyclic angiotensin ii agonists
11/10/2010CN101883767A Abcg2 inhibitor
11/10/2010CN101880281A Thiophane nucleoside analogues and preparation method and application thereof
11/10/2010CN101880273A Benzo-hexahydric N-heterocyclic derivatives, preparation method and application thereof in medicines
11/09/2010US7829728 2-[(S)-1-(9-{Benzyl-1,2-(8-benzyloxy-2-oxo-1,2-dihydroquinolin-5-yl)-2-oxoethyl]-amino}nonyl)pyrrolidin-3-yl -2,2-diphenylacetamide; beta 2 adrenergic receptor agonist, muscarinic receptor antagonist activity; chronic obstructive pulmonary disease and asthma
11/09/2010US7829726 Method for manufacturing imidazole compounds and salts and pseudopolymorphs thereof
11/09/2010US7829719 [3-(6-Chloropyridin-3-yl)-2-methylpropyl](methyl)oxido- lambda 4-sulfanylidenecyanamide; aphidicides
11/09/2010US7829639 Composition for conductive layers in electronic devices
11/09/2010US7829588 Modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof
11/09/2010US7829583 Biphenyl derivatives
11/09/2010US7829580 Cyclic amine derivative having heteroaryl ring
11/09/2010US7829571 monocyte chemotactic protein antagonists such as -(3S)-1-(4-(tert-butylamino)cyclohexyl)-3-(6-(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one, used for the treatment of asthma, multiple sclerosis, arteriosclerosis and rheumatoid arthritis
11/09/2010US7829564 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/09/2010US7829563 sleep disorders; (R)-2-[(S)1-(5-chloro-2-methoxy-phenyl)-3-(6-trifluoromethyl-pyridin-3-yl)-propylamino]-2-(4-fluoro-phenyl)-N-methyl-acetamide
11/09/2010CA2496164C Benzimidazole quinolinones and uses thereof
11/09/2010CA2453623C 6-aryl-4-aminopicolinates and their use as herbicides
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/04/2010WO2010126167A1 Thiophene derivative
11/04/2010WO2010126002A1 Pharmaceutical product containing heterocyclic sulfonamide compound
11/04/2010WO2010125831A1 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
11/04/2010WO2010125402A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
11/04/2010WO2010125350A1 Treatment or prophylaxis of proliferative conditions
11/04/2010WO2010124950A1 New photoinitiators
11/04/2010WO2010124619A1 1,2,3-3h pyridine heterocyclic compounds, their agricultural compositions, their use and their preparation methods
11/04/2010WO2009137081A3 Small molecule inhibitors of plasmodium falciparum dihydroorotate dehydrogenase
11/04/2010WO2009090548A3 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
11/04/2010US20100280208 Thietane compound, polymerizable composition comprising the compound, and use of the composition
11/04/2010US20100280074 Ccr9 inhibitors and methods of use thereof
11/04/2010US20100280036 Modulation of Pathogenicity
1 ... 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 ... 523